ID: ALA3356607

Max Phase: Preclinical

Molecular Formula: C24H49N11O5

Molecular Weight: 571.73

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

Standard InChI:  InChI=1S/C24H49N11O5/c1-14(2)13-18(21(38)34-17(22(39)40)9-6-12-32-24(29)30)35-20(37)16(8-5-11-31-23(27)28)33-19(36)15(26)7-3-4-10-25/h14-18H,3-13,25-26H2,1-2H3,(H,33,36)(H,34,38)(H,35,37)(H,39,40)(H4,27,28,31)(H4,29,30,32)/t15-,16-,17-,18-/m0/s1

Standard InChI Key:  UTSSYMGSFWYKAC-XSLAGTTESA-N

Associated Targets(Human)

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 571.73Molecular Weight (Monoisotopic): 571.3918AlogP: -2.45#Rotatable Bonds: 21
Polar Surface Area: 300.44Molecular Species: ZWITTERIONHBA: 8HBD: 12
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 16#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.07CX Basic pKa: 11.87CX LogP: -4.84CX LogD: -10.33
Aromatic Rings: 0Heavy Atoms: 40QED Weighted: 0.04Np Likeness Score: 0.42

References

1. Han Z, Harris PK, Jones DE, Chugani R, Kim T, Agarwal M, Shen W, Wildman SA, Janetka JW..  (2014)  Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer.,  (11): [PMID:25408834] [10.1021/ml500254r]

Source